Dr. Juan Camilo Arjona Ferreira - 03 Nov 2021 Form 4 Insider Report for Myovant Sciences Ltd.

Role: Chief Medical Officer
Signature: /s/ Matthew Lang, Attorney-in-fact
Issuer symbol: N/A
Transactions as of: 03 Nov 2021
Net transactions value: -$61,698
Form type: 4
Filing time: 05 Nov 2021, 16:27:04 UTC
Previous filing: 07 Oct 2021
Next filing: 01 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MYOV	Common Shares	Options Exercise	$5,446	+700	+0.42%	$7.78	169,291	03 Nov 2021	Direct
transaction	MYOV	Common Shares	Sale	$16,800	-700	-0.41%	$24.00	168,591	03 Nov 2021	Direct	F1
transaction	MYOV	Common Shares	Options Exercise	$24,118	+3,100	+1.8%	$7.78	171,691	04 Nov 2021	Direct
transaction	MYOV	Common Shares	Sale	$74,462	-3,100	-1.8%	$24.02	168,591	04 Nov 2021	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MYOV	Stock Option (Right to Buy)	Options Exercise	$0	-700	-0.44%	$0.000000	158,400	03 Nov 2021	Common Shares	700	$7.78	Direct	F3
transaction	MYOV	Stock Option	Options Exercise	$0	-3,100	-2%	$0.000000	155,300	04 Nov 2021	Common Stock	3,100	$7.78	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares sold pursuant to a 10b5-1 trading plan.
F2	The shares were sold at prices ranging from $24.00 to $24.035. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3	1/4 of the common shares underlying this option vested on August 15, 2018, and 1/16 of the common shares underlying this option vest each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date.